Long-term workforce participation patterns following head and neck cancer

• DOI: 10.1007/s11764-014-0382-2
• Publication Date: 2014-07-24T10:32:46Z
• Authors: Alison Pearce; Aileen Timmons; Eleanor O’Sullivan; Pamela Gallagher; Rachael Gooberman...; Audrey Alforque T...; Michal Molcho; Phyllis Butow; Linda Sharp
• Keywords: Employment; Male; Middle Aged; 16. Peace & justice; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Head and Neck Neoplasms; Quality of Life; Humans; Female; Survivors; Aged

This analysis describes the long-term workforce participation patterns of individuals diagnosed with head and neck cancer (HNC).Survivors of HNC (ICD10 C00-C14, C32) diagnosed at least 8 months previously were identified from the National Cancer Registry Ireland and sent a survey including questions about working arrangements before and since diagnosis. Descriptive statistics and multivariate logistic regression were used to examine the factors that influence workforce participation at 0, 1 and 5 years after diagnosis.Two hundred sixty-four individuals employed at the time of diagnosis responded to the survey, an average 6 years post-diagnosis. Seventy-seven percent took time off work after diagnosis, with a mean work absence of 9 months (range 0-65 months). Fifty-two percent of participants reduced their working hours (mean reduction 15 h/week). The odds of workforce participation following HNC were increased by not being eligible for free medical care (OR 2.61, 95% CI 1.15-5.94), having lip, mouth or salivary gland cancer (compared to cancer of the pharynx or cancer of the larynx, OR 2.79, 1.20-6.46), being self-employed (OR 2.01, 1.07-3.80), having private health insurance (OR 2.06, 1.11-3.85) and not receiving chemotherapy (OR 2.82, 1.31-6.06). After 5 years, only the effect of medical card remained (i.e., medical insurance) (OR 4.03, 1.69-9.62).Workforce participation patterns after HNC are complex and are influenced by cancer, treatment and employment factors.Patients should be informed of the potential impacts of HNC on workforce participation, and clinicians, policy makers and employers should be aware of these potential longer-term effects and related variables.